• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧氟沙星与亚胺培南治疗偶然分枝杆菌和龟分枝杆菌肺部感染

Ofloxacin and imipenem in the treatment of Mycobacterium fortuitum and Mycobacterium chelonae lung infections.

作者信息

Yew W W, Kwan S Y, Wong P C, Lee J

机构信息

Tuberculosis and Chest Unit, Grantham Hospital, Aberdeen, Hong Kong.

出版信息

Tubercle. 1990 Jun;71(2):131-3. doi: 10.1016/0041-3879(90)90009-w.

DOI:10.1016/0041-3879(90)90009-w
PMID:2219463
Abstract

Two patients with Mycobacterium fortuitum and one patient with Mycobacterium chelonae lung infections were treated with ofloxacin and imipenem respectively. Of the former two, one had underlying inactive pulmonary tuberculosis and bronchiectasis and the other had silicosis. The latter had severe underlying bronchiectasis also. The treatments were well tolerated and the patients responded well.

摘要

两名偶然分枝杆菌肺部感染患者和一名龟分枝杆菌肺部感染患者分别接受了氧氟沙星和亚胺培南治疗。前两名患者中,一名有潜在的静止性肺结核和支气管扩张,另一名有矽肺。后者也有严重的潜在支气管扩张。治疗耐受性良好,患者反应良好。

相似文献

1
Ofloxacin and imipenem in the treatment of Mycobacterium fortuitum and Mycobacterium chelonae lung infections.氧氟沙星与亚胺培南治疗偶然分枝杆菌和龟分枝杆菌肺部感染
Tubercle. 1990 Jun;71(2):131-3. doi: 10.1016/0041-3879(90)90009-w.
2
Imipenem in the treatment of lung infections due to Mycobacterium fortuitum and Mycobacterium chelonae: further experience.亚胺培南治疗偶然分枝杆菌和龟分枝杆菌所致肺部感染:更多经验
Clin Infect Dis. 1992 Dec;15(6):1046-7. doi: 10.1093/clind/15.6.1046.
3
[Ofloxacin in the treatment of pulmonary changes caused by Mycobacterium avium and Mycobacterium xenopii].氧氟沙星治疗鸟分枝杆菌和偶发分枝杆菌引起的肺部病变
Pneumonol Alergol Pol. 1992;60(5-6):70-3.
4
New antimycobacterial agents.新型抗分枝杆菌药物
Monaldi Arch Chest Dis. 1996 Oct;51(5):394-404.
5
[Lung infections due to Mycobacterium fortuitum and Mycobacterium chelonae. Reports of nine cases of M. fortuitum infection and four cases of M. chelonae infection].[偶然分枝杆菌和龟分枝杆菌所致肺部感染。9例偶然分枝杆菌感染及4例龟分枝杆菌感染报告]
Kekkaku. 1985 Aug;60(8):429-34.
6
Ofloxacin therapy of Mycobacterium fortuitum infection: further experience.氧氟沙星治疗偶然分枝杆菌感染:更多经验
J Antimicrob Chemother. 1990 May;25(5):880-1. doi: 10.1093/jac/25.5.880.
7
Single daily-dose ofloxacin monotherapy for Mycobacterium fortuitum sternotomy infection.每日单剂量氧氟沙星单药治疗胸骨切开术后偶然分枝杆菌感染。
Chest. 1989 Nov;96(5):1150-2. doi: 10.1378/chest.96.5.1150.
8
[A case of lung infection due to Mycobacterium abscessus].[1例脓肿分枝杆菌所致肺部感染]
Nihon Kokyuki Gakkai Zasshi. 2003 Aug;41(8):546-50.
9
[A case of pulmonaly bulla infection with Mycobacterium fortuitum].[1例肺大疱感染偶然分枝杆菌]
Kansenshogaku Zasshi. 2003 Jun;77(6):451-5. doi: 10.11150/kansenshogakuzasshi1970.77.451.
10
[Pulmonary mycobacteriosis caused by Mycobacterium peregrinum in a young, healthy man].[一名年轻健康男性由偶然分枝杆菌引起的肺部分枝杆菌病]
Nihon Kokyuki Gakkai Zasshi. 2010 Nov;48(11):866-70.

引用本文的文献

1
Are the Newer Carbapenems of Any Value against Tuberculosis.新型碳青霉烯类药物对结核病有任何价值吗?
Antibiotics (Basel). 2022 Aug 7;11(8):1070. doi: 10.3390/antibiotics11081070.
2
Ertapenem and Faropenem against Mycobacterium tuberculosis: in vitro testing and comparison by macro and microdilution.厄他培南和法罗培南对结核分枝杆菌的作用:宏观和微观稀释法的体外检测和比较。
BMC Microbiol. 2020 Aug 31;20(1):271. doi: 10.1186/s12866-020-01954-w.
3
Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria.
致病性非色素沉着或迟色素沉着快速生长分枝杆菌的临床和分类学地位
Clin Microbiol Rev. 2002 Oct;15(4):716-46. doi: 10.1128/CMR.15.4.716-746.2002.
4
Management of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society.机会性分枝杆菌感染的管理:1999年联合结核病委员会指南。英国胸科学会联合结核病委员会小组委员会
Thorax. 2000 Mar;55(3):210-8. doi: 10.1136/thorax.55.3.210.
5
Postantibiotic effects of amikacin and ofloxacin on Mycobacterium fortuitum.阿米卡星和氧氟沙星对偶然分枝杆菌的抗生素后效应。
Antimicrob Agents Chemother. 1993 May;37(5):1001-3. doi: 10.1128/AAC.37.5.1001.
6
Recent changes in taxonomy and disease manifestations of the rapidly growing mycobacteria.快速生长分枝杆菌的分类学和疾病表现的近期变化。
Eur J Clin Microbiol Infect Dis. 1994 Nov;13(11):953-60. doi: 10.1007/BF02111497.
7
Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid.偶然分枝杆菌偶然生物变种以及龟分枝杆菌两个亚群对亚胺培南、头孢美唑、头孢西丁和阿莫西林-克拉维酸的敏感性。
Antimicrob Agents Chemother. 1991 Apr;35(4):773-5. doi: 10.1128/AAC.35.4.773.
8
Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.氧氟沙星。对其抗菌活性、药理学及治疗用途的重新评估。
Drugs. 1991 Nov;42(5):825-76. doi: 10.2165/00003495-199142050-00008.
9
Mycobacteria as a cause of infective exacerbation in bronchiectasis.分枝杆菌作为支气管扩张症感染加重的一个病因。
Postgrad Med J. 1992 Nov;68(805):896-9. doi: 10.1136/pgmj.68.805.896.